Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Early Stage Breast Cancer
Interventions: DRUG: Paclitaxel|DRUG: Neulasta
Sponsor: Dana-Farber Cancer Institute